Product Images Zoledronic Acid
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 3 images provide visual information about the product associated with Zoledronic Acid NDC 25021-826 by Sagent Pharmaceuticals, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
zol0n 0008 01
zol0n 0008 02
This is a chart showing the proportion of complete responders by day 10 in pooled studies related to HCM. The chart includes two drugs, Zoledronic Acid and Pamidronate, with their respective doses of 90mg and 4mg, and the number of participants in each group (n=99 and n=86). The percentage of complete responders is represented on the vertical axis from 0% to 100%, and the horizontal axis represents the drugs being compared. The chart shows that the proportion of complete responders was higher for Zoledronic Acid compared to Pamidronate on day 10. The significance level of this difference is also displayed (P=0.002).*
zol0n 0008 03
This text provides information about Zoledronic Acid Injection, which is used for intravenous infusion. The injection contains 4mg of zoledronic acid per 100 mL and is not recommended to mix with calcium-containing infusion solutions. It is recommended to undergo an infusion for at least 15 minutes. The container is sterile, preservative-free, DEHP-free, and PVC-free, and is not made with natural rubber latex. The text contains information about the manufacturer, SAGENT Pharmaceuticals, and the container's LOT EXP number.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.